KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Intangibles (2016 - 2026)

Biogen has reported Intangibles over the past 18 years, most recently at $9.1 billion for Q1 2026.

  • For Q1 2026, Intangibles fell 5.54% year-over-year to $9.1 billion; the TTM value through Mar 2026 reached $9.1 billion, down 5.54%, while the annual FY2025 figure was $9.2 billion, 5.29% down from the prior year.
  • Intangibles for Q1 2026 was $9.1 billion at Biogen, down from $9.2 billion in the prior quarter.
  • Over five years, Intangibles peaked at $9.8 billion in Q3 2024 and troughed at $100.0 million in Q3 2023.
  • A 5-year average of $6.0 billion and a median of $8.3 billion in 2024 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: tumbled 95.02% in 2023 and later surged 9705.5% in 2024.
  • Year by year, Intangibles stood at $1.9 billion in 2022, then skyrocketed by 352.03% to $8.4 billion in 2023, then increased by 15.88% to $9.7 billion in 2024, then decreased by 5.29% to $9.2 billion in 2025, then decreased by 1.36% to $9.1 billion in 2026.
  • Business Quant data shows Intangibles for BIIB at $9.1 billion in Q1 2026, $9.2 billion in Q4 2025, and $9.3 billion in Q3 2025.